Clinical Trials Logo

Filter by:
NCT ID: NCT04274660 Completed - Type 2 Diabetes Clinical Trials

Evaluation of Diabetes and WELLbeing Programme

DWELL
Start date: September 8, 2017
Phase: N/A
Study type: Interventional

This study evaluates the impact of 'DWELL' - a 12-week psycho-social education programme designed to help people with type 2 diabetes to better self-manage their condition. Up to 600 patients will participate in the programme, while a non-intervention group will receive routine care for their diabetes

NCT ID: NCT04271280 Completed - Clinical trials for Cardiovascular Diseases

Treatment of High and Very High riSk Dyslipidemic pAtients for the PreveNTion of CardiOvasculaR Events

SANTORINI
Start date: March 17, 2020
Phase:
Study type: Observational

High and Very High Risk cardiovascular patient journeys seems to vary from country to country, and current understanding of the process is incomplete. This real-life observational study which documents meaningful patient journey-related parameters can be expected to provide meaningful insight into the care process, country-by-country.

NCT ID: NCT04270903 Completed - Skin Pigmentation Clinical Trials

EPR (Electron Paramagnetic Resonance) as Method of Non-invasive Characterization of Melanin Content in Skins With Different Phototypes

Start date: March 22, 2019
Phase:
Study type: Observational

The aim of this study is to assess the signal of melanin using Electron Paramagnetic resonance (EPR). Melanin is a paramagnetic pigment detectable by EPR. Recent advances in instrumentation allows the application of EPR in human beings. The characterization of melanin by EPR could be potentially interesting in the context of melanoma detection and characterization. While another clinical study is currently ongoing aiming at demonstrating the feasibility of the non-invasive detection of the EPR signal of melanin in melanoma patients, it is crucial to have a control group with healthy skin. The aim of the present study is to assess the influence of skin pigmentation of the EPR signal recorded. In the present clinical study, the EPR signal of melanin will be characterized in healthy skin with different phototypes (1-2, 3-4, 5-6) to assess the potential influence of skin pigmentation on the EPR signal.

NCT ID: NCT04270487 Completed - Clinical trials for Irritable Bowel Syndrome

The DOMINO Trial: Diet Or Medication in Irritable Bowel syNdrOme

DOMINO
Start date: July 26, 2018
Phase: Phase 4
Study type: Interventional

A randomized controlled trial to evaluate the short-term efficacy and long-term health economic impact of a dietary intervention compared to pharmacotherapy with a musculotropic spasmolytic agent for newly diagnosed or newly treated irritable bowel syndrome in primary care.

NCT ID: NCT04269434 Completed - Clinical trials for Chlamydia Trachomatis Infection

GonoScreen: Efficacy of Screening STIs in MSM

GonoScreen
Start date: September 21, 2020
Phase: N/A
Study type: Interventional

A Multicentre, controlled, randomized trial of 3 site (urethra, pharynx and rectum) sampling performed every 3 months (3x3) for Neisseria gonorrhoea (Ng)/Chlamydia trachomatis (Ct) screening (comparator) vs. no screening (intervention).

NCT ID: NCT04268875 Completed - In-stent Restenosis Clinical Trials

Morphological Parameters of In-stent RESTenosis Assessed and Identified by OCT

RESTO
Start date: December 11, 2019
Phase: N/A
Study type: Interventional

The statistical risk of intrastent stenosis has fallen considerably with the emergence of latest generation coated stents (drug-eluting stents: DES). The number and clinical lifespan of stents implanted over the last twenty-five years, however, explain the fact that restenosis remains a not unusual clinical problem which is expressed as a recurrence of angina or of an acute coronary syndrome (ACS). The mechanisms involved in this restenosis are multifactorial in nature and differ depending on the type of stent and the time since the restenosis occurred. In symptomatic stent restenosis (angina or acute coronary syndrome), a further angioplasty is usually required, occasionally on an emergency basis. Coronary angiography is often not capable of explaining the mechanical causes of this complication. Optical coherence tomography (OCT), a high-resolution endocoronary imaging technique can assist in the understanding of the mechanism of restenosis and guide treatment. OCT during angiography provides a detailed analysis of the stents and potential complications: the presence of neoatherosclerosis with or without plaque rupture, intimal hyperplasia, stent under-deployment, stent fracture and distal or proximal progression of the atherosclerosis. The investigators propose a prospective, multicentre study of all cases of intrastent restenosis, examined by angiography, causing clinical features involving stable angina and acute coronary syndrome. The coronary artery involved will be routinely studied by OCT for a mechanical cause of the intrastent restenosis. The routine use of intrastent OCT may assist in the understanding of causes of restenosis and in the decision on appropriate treatment. There are several possible treatments for restenosis, including balloon angioplasty, coated balloon angioplasty, stenting or aorto-coronary bypass graft surgery.

NCT ID: NCT04268732 Completed - Clinical trials for Acute Febrile Illness

Acute Undifferentiated Fever in Ethiopia

Start date: June 1, 2019
Phase:
Study type: Observational

A cross-sectional study on acute undifferentiated fever and the utility of biomarkers in differentiating bacterial from viral infection among acute febrile patients in Gondar, northwest Ethiopia.

NCT ID: NCT04266756 Completed - Healthy Clinical Trials

A Study of Selexipag in Healthy Male Participant

Start date: January 23, 2020
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the pharmacokinetic (PK) of selexipag and ACT-333679 following single oral administration of the matrix tablet and the encapsulated pellets of selexipag, each with 3 different release profiles, as compared to selexipag immediate release (IR) tablets in healthy male participants.

NCT ID: NCT04266509 Completed - Healthy Volunteers Clinical Trials

Study to Evaluate the Effect of Repeat-Dose Rifampin on the Pharmacokinetics (PK) of PF-06651600

Start date: June 25, 2020
Phase: Phase 1
Study type: Interventional

Study to Evaluate the Effect of Repeat-Dose Rifampin on the pharmacokinetics (PK) of PF-06651600.

NCT ID: NCT04266496 Completed - Fluid Overload Clinical Trials

Discovering the Effect of Venous Insufficiency on Nocturia

DEVINe
Start date: January 1, 2020
Phase: N/A
Study type: Interventional

With this prospective controlled trial, we hope to obtain more information about the coexistence between venous insufficiency and nocturia. In our opinion, venous insufficiency (CEAP 2-3a) leads to an increase in fluid accumulation in the lower limbs due to moving around all day. When laying down during nighttime, this fluid is reabsorbed into the systimic fluid pool, leading to an increase in diuresis and thus an increase in nocturnal voiding. Aim of this study is observe difference in nocturnal frequency and urine production before and after surgical treatment of venous insufficiency.